Tasas de abstinencia de vareniclina frente a bupropión y terapia sustitutiva con nicotina en la cesación del tabaco en atención primaria
- 30 September 2011
- journal article
- research article
- Published by Elsevier BV in Atencion Primaria
- Vol. 43 (9), 482-489
- https://doi.org/10.1016/j.aprim.2010.09.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokersCurrent Medical Research and Opinion, 2010
- Comparative Effectiveness of 5 Smoking Cessation Pharmacotherapies in Primary Care ClinicsJAMA Internal Medicine, 2009
- Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practiceTherapeutic Advances in Respiratory Disease, 2009
- Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking CessationClinical Drug Investigation, 2009
- Effectiveness of smoking cessation interventions among adults: a systematic review of reviewsEuropean Journal of Cancer Prevention, 2008
- Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trialsCMAJ : Canadian Medical Association Journal, 2008
- Análisis coste-efectividad de vareniclina (Champix®) en el tratamiento del tabaquismo en EspañaAnales de Medicina Interna, 2008
- Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the NetherlandsCurrent Medical Research and Opinion, 2007
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987